LONDON--(BUSINESS WIRE)--The intraosseous infusion devices market is poised to grow by USD 96.40 million during 2020-2024 progressing at a CAGR of over 4% during the forecast period. For a More ...
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Intraosseous Infusion Devices Market: Global Industry Analysis & Opportunity Assessment, 2016-2026" report to their ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global intraosseous infusion devices market is positioned for robust growth, with sales expected to increase from USD 5,065.8 million in 2025 to USD 10,463 ...
Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts ...
Intraosseous cannulation is an accepted means to achieve vascular access when peripheral venous access is not available. It is common practice to flush the intraosseous cannula with saline prior to ...
FDA pre-submission meeting date supporting de novo application secured Broad method and device patents granted by USPTO NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results